Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

prolactinoma/obezitate

Linkul este salvat în clipboard
Pagină 1 din 58 rezultate
BACKGROUND Prolactinoma has been associated with obesity. As opposed to ACTH- and GH-secreting adenoma, the mechanism by which macroprolactinoma causes obesity has not been fully understood. Having seen patients with both prolactinoma and obesity and more recent literature on brain dopamine,

Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE Increasing evidence exists that hyperprolactinemia alters metabolic profile. The mechanism of this effect is unknown. We aimed to investigate the differences between the metabolic profile of patients with prolactinomas and nonfunctional pituitary adenomas and to evaluate the impact of

NUTRITIONAL AND METABOLIC ASSESSMENT IN OVERWEIGHT PATIENTS WITH AND WITHOUT HYPERPROLACTINEMIA CAUSED BY PROLACTINOMA.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND prolactinomas are pituitary adenomas that express and secrete prolactin. These patients are overweight and the mechanisms are being studied. OBJECTIVE assess nutritional and metabolic status of overweight patients with and without hyperprolactinemia caused by prolactinoma and compare

Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE It has recently been shown that increased body weight is associated with prolactinomas and that weight loss occurs with normalization of prolactin levels. On the other hand, decreased dopaminergic tone in humans is well correlated with obesity. The objective of this study was to correlate

Syndrome of galactorrhea, amenorrhea, and obesity as possible indicators of prolactinoma: a case study approach.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Four female patients were found to have microadenomas and high prolactin levels, but the symptoms of the syndrome varied among the patients. Three of four patients had overt galactorrhea, obesity, and amenorrhea. One patient was postmenopausal, and another showed menstrual irregularities. Two

Prolactinoma-associated obesity treated with bupropion and methylphenidate.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
A 57-year-old obese woman with hypertension, diabetes mellitus, osteoporosis, and a 40-year history of secondary amenorrhea was diagnosed with corticotropin-dependent Cushing's syndrome. Dynamic endocrine testing and radiological evaluation did not reveal definitively the source of the excess
OBJECTIVE To evaluate the characteristics of pituitary adenomas that produce both prolactin and adrenocorticotropin. METHODS Between 2002 and 2011, we reviewed the data of 336 patients undergoing transsphenoidal surgery at Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

Polycystic ovary syndrome and prolactinoma association.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Hyperprolactinemia is the most common pituitary hormone hypersecretion syndrome in both men and women. Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting 5%-10% of reproductive age women. Here, we present a patient with irregular menses, obesity, hirsutism and

Body self-image disturbances in women with prolactinoma.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
To evaluate body dissatisfaction and distorted body self-image in women with prolactinoma.Body dissatisfaction and distorted body self-image were evaluated in 80 women with prolactinoma. All patients were in menacme, 34% had normal body mass index (BMI),

Obesity is common at diagnosis of childhood pituitary adenoma, and may persist following successful treatment.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
There is a paucity of data describing long-term outcomes of paediatric patients with pituitary adenoma. In this report we describe clinical features, treatment and outcomes of a paediatric cohort.Retrospective cohort study.24

Effect of cabergoline on metabolism in prolactinomas.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND Hyperprolactinemia has been implicated in the pathogenesis of obesity and glucose intolerance and is reportedly associated with an impaired metabolic profile. The current study aimed at investigating the effects of 12- and 60-month treatment with cabergoline (CAB) on metabolic syndrome

[The therapy of a macroprolactinoma with the intramuscular application of a long-acting bromocriptine preparation].

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
METHODS Three years ago, a now 26-year-old woman with secondary amenorrhoea was found to have a prolactinoma which was treated with bromocriptine. However, because of side effects and psychosocial problems she took the drug only irregularly. There were no neurological symptoms and the visual fields
Deranged metabolic profiles and insulin resistance (IR) have been documented in patients with prolactinomas. Few data are yet available on the apolipoprotein (apo) B/apoA-I ratio and its relationship with IR in patients with prolactinomas. This study was aimed to evaluate the level of apoB/apoA-I
Hyperprolactinemia and prolactinoma in patients with long-term primary hypothyroidism have been recognized for decades. We report a case of 57-year-old female patient with lingual thyroid and cretinism who had a high serum prolactin level (greater than 200 ng/ml) and a pituitary tumor with
Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge